Evaxion Biotech started at buy with $23 stock price target at Ladenburg Thalmann

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Evaxion Biotech A/S ADR

Evaxion Biotech A/S discovers and develops novel immunotherapies for cancer and infectious diseases. The company was founded by Niels Iversen Møller and Andreas Holm Mattsson on 11 August, 2008 and is headquartered in Copenhagen, Denmark.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply